Dark Forest Capital Management LP Sage Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $235,352 - $398,185	22,245 New	22,245 $241,000
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $396,500 - $580,753	9,754 Added 306.54%	12,936 $608,000
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $118,593 - $148,185	3,182 New	3,182 $133,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $581 - $778	18 Added 600.0%	21 $1,000
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $82 - $113	3 New	3 $0
Q1 2022 May 13, 2022	SELL	$30.71 - $45.71 $30 - $45	-1 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$37.06 - $47.11 $2,705 - $3,439	-73 Reduced 98.65%	1 $0
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $7,407 - $10,556	-184 Reduced 71.32%	74 $3,000
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $14,159 - $20,456	258 New	258 $15,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.